A66

News alerts, weekly reports and conference planners

Company:

Inje University College of Medicine, The University of Auckland

Drug class:

PI3K inhibitor

PTEN mutation	Endometrial Cancer	PTEN mutation	Endometrial Cancer	A66 Resistant: D – Preclinical A66 Resistant : D	A66 Resistant: D – Preclinical A66 Resistant : D
PTEN mutation	Endometrial Cancer	PTEN mutation	Endometrial Cancer	A66 + AZD6482 Sensitive: D – Preclinical A66 + AZD6482 Sensitive : D	A66 + AZD6482 Sensitive: D – Preclinical A66 + AZD6482 Sensitive : D
PTEN mutation	Endometrial Cancer	PTEN mutation	Endometrial Cancer	GSK2636771 + A66 Sensitive: D – Preclinical GSK2636771 + A66 Sensitive : D	GSK2636771 + A66 Sensitive: D – Preclinical GSK2636771 + A66 Sensitive : D

Associations
(3)